Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katrin Farker"'
Autor:
Laura Weisbach, Anna K. Schuster, Michael Hartmann, Pauline Dürr, Melanie I. Then, Wahram Andrikyan, Martin F. Fromm, Renke Maas, Katrin Farker
Publikováno v:
British Journal of Clinical Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfc67986c0ef3fc9e5fd67fb1ae0a20b
https://doi.org/10.1111/bcp.15730
https://doi.org/10.1111/bcp.15730
Autor:
Laura Weisbach, Anna K. Schuster, Michael Hartmann, Martin F. Fromm, Renke Maas, Katrin Farker
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 7; Pages: 1933
Liver disease is a common condition worldwide that can cause alterations in drug disposition and susceptibility to drug toxicities, with increased risk of adverse drug reactions. European Summaries of Product Characteristics (SmPCs) and United States
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc3fc02f621f4f8e1eab4ec7128d7e3b
https://pubmed.ncbi.nlm.nih.gov/35407541
https://pubmed.ncbi.nlm.nih.gov/35407541
Autor:
Dominik, Rottenkolber, Sven, Schmiedl, Marietta, Rottenkolber, Katrin, Farker, Karen, Saljé, Silke, Mueller, Marion, Hippius, Petra A, Thuermann, Joerg, Hasford
Publikováno v:
Pharmacoepidemiology and drug safety. 20(6)
German hospital reimbursement modalities changed as a result of the introduction of Diagnosis Related Groups (DRG) in 2004. Therefore, no data on the direct costs of adverse drug reactions (ADRs) resulting in admissions to departments of internal med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba2046a5655c13708cea924be4ed4686
https://pubmed.ncbi.nlm.nih.gov/21384463
https://pubmed.ncbi.nlm.nih.gov/21384463
Autor:
Marion, Hippius, Christiane, Buchardt, Katrin, Farker, Urs Dieter, Kuhn, Ilselore R, Reimann, Annemarie, Hoffmann
Publikováno v:
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie. 54(5-6)
Inter-subject variability in therapeutic drug response and drug toxicity is a major problem in clinical practice. In this field genetic polymorphisms of drug metabolizing enzymes play an important role. In a multicenter study supported by the German
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::132490d73f3d0b55076a8c7fad7ba566
https://pubmed.ncbi.nlm.nih.gov/12877354
https://pubmed.ncbi.nlm.nih.gov/12877354